Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-17 5:28 pm Purchase | 2025-06-16 | 13G | ADC THERAPEUTICS SA SHS ADCT | Point72 Asset Management, L.P. | 7,831,425 7.000% | 7,831,425 (New Position) | Filing History |
| 2025-06-17 5:28 pm Purchase | 2025-06-05 | 13G | XILIO THERAPEUTICS INC XLO | Point72 Asset Management, L.P. | 285,714 7.200% | 285,714 (New Position) | Filing History |
| 2025-06-09 4:10 pm Purchase | 2025-06-06 | 13G | IDEAYA BIOSCIENCES INC IDYA | Point72 Asset Management, L.P. | 4,412,432 5.000% | 4,342,982 (+6253.39%) | Filing History |
| 2025-06-04 4:32 pm Purchase | 2025-05-29 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 4,401,659 5.100% | 4,401,659 (New Position) | Filing History |
| 2025-05-21 4:52 pm Purchase | 2025-05-20 | 13G | CYBIN INC HELP | Point72 Asset Management, L.P. | 1,326,185 6.300% | 1,033,788 (+353.56%) | Filing History |
| 2025-05-19 4:10 pm Purchase | 2025-05-16 | 13G | TELADOC HEALTH, INC. TDOC | Point72 Asset Management, L.P. | 8,826,350 5.000% | 1,358,956 (+18.20%) | Filing History |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management, L.P. | 1,212,728 5.800% | -35,508 (-2.84%) | Filing History |
| 2025-05-15 4:34 pm Sale | 2025-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Point72 Asset Management, L.P. | 3,739,318 7.800% | -490,984 (-11.61%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management, L.P. | 3,552,555 7.700% | 1,015,497 (+40.03%) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | PEPGEN INC PEPG | Point72 Asset Management, L.P. | 2,675,937 8.200% | 804,742 (+43.01%) | Filing History |
| 2025-05-15 4:31 pm Purchase | 2025-03-31 | 13G | MOBILEYE GLOBAL INC MBLY | Point72 Asset Management, L.P. | 6,246,097 6.200% | 1,193,774 (+23.63%) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | SPHERE ENTERTAINMENT CO. SPHR | Point72 Asset Management, L.P. | 1,535,450 5.300% | -569,841 (-27.07%) | Filing History |
| 2025-05-15 4:28 pm Sale | 2025-03-31 | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | Point72 Asset Management, L.P. | 1,755,143 5.700% | -712,985 (-28.89%) | Filing History |
| 2025-05-15 4:27 pm Purchase | 2025-03-31 | 13G | TOWER SEMICONDUCTOR LTD TSEM | Point72 Asset Management, L.P. | 7,653,786 6.900% | 2,037,579 (+36.28%) | Filing History |
| 2025-05-15 4:26 pm Sale | 2025-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 1,907,831 7.000% | -452,100 (-19.16%) | Filing History |
| 2025-05-15 3:58 pm Sale | 2025-03-31 | 13G | TELADOC HEALTH, INC. TDOC | Point72 Asset Management, L.P. | 7,467,394 4.300% | -4,999,077 (-40.10%) | Filing History |
| 2025-05-15 3:57 pm Sale | 2025-03-31 | 13G | ARRAY TECHNOLOGIES INC ARRY | Point72 Asset Management, L.P. | 3,054,653 2.000% | -4,559,334 (-59.88%) | Filing History |
| 2025-05-15 3:55 pm Sale | 2025-03-31 | 13G | ATYR PHARMA INC ATYR | Point72 Asset Management, L.P. | 71,134 3.200% | -54,862 (-43.54%) | Filing History |
| 2025-05-15 3:54 pm Sale | 2025-03-31 | 13G | DYNE THERAPEUTICS INC DYN | Point72 Asset Management, L.P. | 1,669,342 1.500% | -3,527,255 (-67.88%) | Filing History |
| 2025-05-15 3:53 pm Sale | 2025-03-31 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | Point72 Asset Management, L.P. | 5,087 0.000% | -1,465,224 (-99.65%) | Filing History |